is compounded tirzepatide being discontinued FDA says tirzepatide shortage is

As you get used to taking Mounjaro, your side effects will calm down

The disadvantages are slightly lower efficacy and the requirement for daily use rather than weekly injections. GLP-1 medications work by suppressing appetite

In 2022, Eli Lilly introduced Mounjaro (tirzepatide), a dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) receptor agonist, as a direct competitor of Ozempic

doi: 10.1016/j.ijcard.2022.06.027

The standard tirzepatide dosing schedule increases the dose every 4 weeks, so you cycle through adjustment periods repeatedly

For Mounjaro diabetes renewals, continued documentation of glycemic management, typically through A1C levels, is required